Evidence map›Paper›PMID 41677663›Full record

ArticleCells2026

Integrative Machine Learning and Experimental Validation Identify FIS1 as a Candidate Biomarker Linked to Mitochondrial Dynamics in Pulmonary Hypertension.

Yu Zhang, Qing Dai, Lijun Gong, Runxiu Zheng, Wei Huang, Feiying Wang, Rong Yuan, Lan Song, Aiguo Dai

Abstract read
In one paragraph

Article in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yu ZhangSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Qing DaiHunan Provincial Key Laboratory of Vascular Biology and Translational Medicine, Changsha 410208, China.
Lijun GongHunan Provincial Key Laboratory of Vascular Biology and Translational Medicine, Changsha 410208, China.
Runxiu ZhengSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Wei HuangSchool of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Changsha 410208, China.
Feiying WangHunan Provincial Key Laboratory of Vascular Biology and Translational Medicine, Changsha 410208, China.
Rong YuanHunan Provincial Key Laboratory of Vascular Biology and Translational Medicine, Changsha 410208, China.
Lan SongHunan Provincial Key Laboratory of Vascular Biology and Translational Medicine, Changsha 410208, China.
Aiguo DaiHunan Provincial Key Laboratory of Vascular Biology and Translational Medicine, Changsha 410208, China.ORCID 0009-0003-3038-0358

Funding

Hunan Provincial Natural Science Foundation No. 2025JJ90012Key Project of Postgraduate Scientific Research and Innovation in Hunan Province CX20251156the National Key Laboratory Cultivation Base of Chinese Medicinal Powder and Innovative Medicinal Jointly Established by Province and Ministry Foundation 2024PTKF1007the National Natural Science Foundation of China No. 82500077the Natural Science Foundation of Hunan Province 2025JJ60771
6 · The paper itself

Abstract

Pulmonary hypertension (PH) is characterized by progressive pulmonary vascular remodeling and a paucity of effective therapeutic interventions. Although dysregulated mitochondrial dynamics are implicated in this remodeling process, the key regulatory molecules and downstream mechanisms remain incompletely defined. This study aimed to systematically characterize molecular alterations associated with mitochondrial dynamics in PH and to explore the functional relevance and potential mechanisms of prioritized candidate genes. We integrated transcriptomic datasets from PH models with MitoCarta annotations to identify mitochondria-related differentially expressed genes. Candidate genes were prioritized using WGCNA and three machine-learning algorithms (LASSO, SVM-RFE, and random forest). These candidates were then experimentally evaluated in a hypoxia-induced PH mouse model and hypoxia-stimulated mouse pulmonary artery smooth muscle cells (mPASMCs) using qRT-PCR, Western blotting, immunohistochemistry, and transmission electron microscopy. Functional assays and assessments of mitochondrial injury were performed to investigate pathogenic relevance. Our analysis identified four key genes, with FIS1 showing high ROC/AUC-based discriminatory performance in both the training dataset and the independent replication dataset. Hypoxia was associated with increased FIS1 expression, mitochondrial fragmentation, loss of mitochondrial membrane potential, and ROS accumulation. We further observed that FIS1 knockdown suppressed mPASMC proliferation and migration, alleviated mitochondrial injury, and attenuated ferroptosis-associated alterations, accompanied by reduced lipid peroxidation, decreased Fe

Indexed as

BiomarkersHypertension, PulmonaryMachine LearningMembrane ProteinsMitochondrial DynamicsMitochondrial ProteinsAnimalsCell ProliferationHumansHypoxiaMaleMiceMice, Inbred C57BLMitochondriaMyocytes, Smooth MusclePulmonary ArteryBiomarkersFIS1 protein, mouseMembrane ProteinsMitochondrial ProteinsferroptosisFIS1machine learningmitochondrial dynamicspulmonary hypertension

Identifiers

PMID41677663
PMCPMC12896716

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.